Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
Renee L. Hajnik(The University of Texas Medical Branch at Galveston), Haitao Hu(Northwest A&F University), Jessica A. Plante(The University of Texas Medical Branch at Galveston), Jie Sun(Carter Center), Scott C. Weaver(The University of Texas Medical Branch at Galveston), Lynn Soong(The University of Texas Medical Branch at Galveston), Awadalkareem Adam(The University of Texas Medical Branch at Galveston), Dionna Scharton(The University of Texas Medical Branch at Galveston), Jiaren Sun(The University of Texas Medical Branch at Galveston), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), David H. Walker(The University of Texas Medical Branch at Galveston), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Yuejin Liang(The University of Texas Medical Branch at Galveston), Chaojie Zhong(The University of Texas Medical Branch at Galveston), Nicholas C. Hazell(The University of Texas Medical Branch at Galveston), Tian Wang(Wuhan University), Srinivasa Reddy Bonam(Indian Institute of Chemical Biology), Jinyi Tang(Carter Center), Yang Liu(The University of Texas Medical Branch at Galveston), Grace Rafael(The University of Texas Medical Branch at Galveston), Kenneth S. Plante(World Health Organization - Pakistan)
Cited by 129
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Scientists’ warning to humanity: microorganisms and climate change
|Nature Reviews Microbiology|2019|2.1k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Lysosomes as a therapeutic target
|Nature Reviews Drug Discovery|2019|751